A unified dose response relationship to predict high dose fractionation response in the lung cancer stereotactic body radiation therapy

TS Kehwar, KL Chopra, DV Rai - Journal of Medical Physics, 2017 - journals.lww.com
Aim: This study is designed to investigate the superiority and applicability of the model
among the linear-quadratic (LQ), linear-quadratic-linear (LQ-L) and universal-survival-curve …

[HTML][HTML] Comparison of three radiobiological models in stereotactic body radiotherapy for non-small cell lung cancer

JY Lu, Z Lin, PX Lin, BT Huang - Journal of Cancer, 2019 - ncbi.nlm.nih.gov
Objective: The applicability of the linear quadratic (LQ) model to local control (LC) modeling
after hypofractionated radiotherapy to treat lung cancer is highly debated. To date, the …

Revisiting the formalism of equivalent uniform dose based on the linear-quadratic and universal survival curve models in high-dose stereotactic body radiotherapy

MKH Chan, CL Chiang - Strahlentherapie und Onkologie, 2021 - Springer
Purpose To examine the equivalent uniform dose (EUD) formalism using the universal
survival curve (USC) applicable to high-dose stereotactic body radiotherapy (SBRT) …

Applicability of the linear-quadratic formalism for modeling local tumor control probability in high dose per fraction stereotactic body radiotherapy for early stage non …

M Guckenberger, RJ Klement, M Allgäuer… - Radiotherapy and …, 2013 - Elsevier
Background and purpose To compare the linear-quadratic (LQ) and the LQ-L formalism
(linear cell survival curve beyond a threshold dose d T) for modeling local tumor control …

Mathematical model combined with microdosimetric kinetic model for tumor volume calculation in stereotactic body radiation therapy

H Nakano, T Shiinoki, S Tanabe, S Utsunomiya… - Scientific Reports, 2023 - nature.com
We proposed a new mathematical model that combines an ordinary differential equation
(ODE) and microdosimetric kinetic model (MKM) to predict the tumor-cell lethal effect of …

Universal survival curve and single fraction equivalent dose: useful tools in understanding potency of ablative radiotherapy

C Park, L Papiez, S Zhang, M Story… - International Journal of …, 2008 - Elsevier
PURPOSE: Overprediction of the potency and toxicity of high-dose ablative radiotherapy
such as stereotactic body radiotherapy (SBRT) by the linear quadratic (LQ) model led to …

Developing a clinical-radiomic prediction model for 3-year cancer-specific survival in lung cancer patients treated with stereotactic body radiation therapy

BT Huang, Y Wang, PX Lin - Journal of Cancer Research and Clinical …, 2024 - Springer
Purpose The study aims to develop and validate a combined model for predicting 3-year
cancer-specific survival (CSS) in lung cancer patients treated with stereotactic body …

Prediction of radiation-induced changes in the lung after stereotactic body radiation therapy of non–small-cell lung cancer

I Kyas, H Hof, J Debus, W Schlegel… - International Journal of …, 2007 - Elsevier
Purpose: To estimate the risk of radiation-induced changes in the lung before single-dose
treatment (stereotactic body radiation therapy [SBRT]) of lung cancer, the quantitative dose …

Tumor control probability modeling for stereotactic body radiation therapy of early-stage lung cancer using multiple bio-physical models

F Liu, A Tai, P Lee, T Biswas, GX Ding, I El Naqa… - Radiotherapy and …, 2017 - Elsevier
This work is to analyze pooled clinical data using different radiobiological models and to
understand the relationship between biologically effective dose (BED) and tumor control …

What Would Be the Most Appropriate α/β Ratio in the Setting of Stereotactic Body Radiation Therapy for Early Stage Non‐Small Cell Lung Cancer

A Chi, S Wen, Z Liao, J Fowler, J Xu… - BioMed research …, 2013 - Wiley Online Library
We hypothesize that the correlation between the radiation dose expressed as the
biologically effective dose (BED) and the clinical endpoints will correlate better as the value …